Pfizer testing use of pneumococcal vaccine alongside COVID-19 booster
Pfizer administered the first set of jabs to volunteers of a new study of subjects 65 and older, exploring the co-administration of the company’s 20-valent pneumococcal conjugate vaccine (20vPnC) candidate when followed by a booster shot of Pfizer’s current COVID-19 vaccine, the company said on Monday.The 20vPnC vaccine candidate is currently in development to prevent […]
Continue Reading